Abstracts of the 4th Congress of ECCO the European Crohn's and Colitis Organisation S111 colitis (UC) 2 3 cases per 100.000 per year. So far the incidence of pediatric IBD in Hungary is unknown. Methods: The participating institutes are requested to fill out a questionnaire (78 parameters) about every newly diagnosed IBD patients younger than 18 years. The questionnaire is about epidemiological and antropometrical data, main symptoms, diagnostic procedures (endoscopy, CT, MRI), and the detailed results of histological and imaging procedures. Results: Between 01. 01.2007 and 30.09.2008 223 newly diagnosed cases of IBD were prospectively identified: 139 cases of CD, 69 cases of UC and 15 cases of indeterminate colitis. As a result the incidence of childhood IBD was 6.13 cases per 100.000, with the incidence of CD being 4.07 cases per 100.000 per year, the incidence of UC 1.67 cases per 100.000 per year and the incidence of indeterminate colitis 0.40 cases per 100.000 per year. The mean age at diagnosis was 13 years (range: 1.5 18 year). There was a male preponderance in CD, in contrast, sex ratio in UC patients were equal. Positive family history of IBD was registered in 7.8% of patients and 9.2% of patients with CD were reported to have a fistula. Ileoscopy rate was only 48% technical problem was the most common reason for the lack of ileal intubation. Oesophagogastro-duodenoscopy was performed in 50% of all cases. In 35% were MRI or CT scan made for the detailed verification of the disease. Conclusions: The incidences reported in the first 21 months of HUPIR are similar to the European and North American data. The dominance of CD proved to be also consistent with other studies. Almost 10% of the patients with CD had fistula. Ileal intubation and oesophago-gastro-duodenoscopy were performed in the half of the cases, and this rate should be improved in the future.
Introduction: The pregnane X receptor (PXR), also known as NR1I2 (nuclear receptor subfamily 1, group I, member 2), is a nuclear receptor encoded by the PXR/NR1I2 gene. The PXR/NR1I2 gene has recently been reported to be associated with susceptibility to inflammatory bowel disease (IBD) (Gastroenterology 2006; 130:341 8) . However, since a subsequent case-control study failed to replicate this association in an independent population, further replication studies in different ethnic cohorts are required. We therefore investigated this potential association in a large European IBD cohort. Aims and Methods: Genomic DNA from 2823 Caucasian individuals including 859 patients with Crohn's disease (CD), 464 patients with ulcerative colitis (UC), and 1500 healthy unrelated controls was analyzed for eight single nucleotide polymorphisms (SNPs) in the pregnane X receptor (PXR/NR1I2) gene (rs12721602, rs3814055, rs1523128, rs1523127, rs12721607, rs6785049, rs2276707, rs3814057 subtotal, left-sided colitis was found in 125 (29.2%) patients, in case of 32 patients there were no data about the localization of inflammation. According to severity of inflammation distribution of patients was the following: mild inflammation was found in 70 (16.4%) cases, moderate in 237 (55.4%), severe in 61 (14.3%) patient, in case of 60 patient data was lacking. Massive bleeding as a complication of NUC occurred in 10 (2.3%) patients, 4 of them underwent surgery. NUC was the cause of disability in 79 (18.5%) patients. Conclusions: It's the first registry of NUC patients in Republic of Tatarstan which covered 428 NUC patients and revealed incidence of NUC as 11.4 per 100000 of population. NUC incidence is the same in men and women. Most of patients have distal type of NUC with moderate activity. Frequency of massive bleeding as NUC complication is 2.3%. Background: Crohn's disease (CD) is a chronic inflammatory bowel disease with periods of relapse and remission. Role of anxiety and depression in CD patients in remission has been poorly studied. We hypothesized that despite staying in remission, anxiety and depression symptoms have an import role in CD patients. Aim of the study was to evaluate the presence of anxiety and depression symptoms in CD patients in remission and potential Downloaded from https://academic.oup.com/ecco-jcc/article-abstract/3/1/S111/2393414 by guest on 02 April 2019
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